These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 16306796)
1. Blood pressure and proteinuria after cessation of a brief renin-angiotensin system blockade in young and adult Lyon hypertensive rats. Naelten G; Trigo LF; Lo M J Cardiovasc Pharmacol; 2005 Dec; 46(6):740-5. PubMed ID: 16306796 [TBL] [Abstract][Full Text] [Related]
2. Persistent effects on blood pressure and renal function of perindopril alone or combined with losartan in Lyon hypertensive rats. Naelten G; Liu KL; Chapuis B; Lo M Am J Hypertens; 2005 May; 18(5 Pt 1):699-706. PubMed ID: 15882554 [TBL] [Abstract][Full Text] [Related]
3. Differential evolution of blood pressure and renal lesions after RAS blockade in Lyon hypertensive rats. Bertram D; Blanc-Brunat N; Sassard J; Lo M Am J Physiol Regul Integr Comp Physiol; 2002 Nov; 283(5):R1041-5. PubMed ID: 12376396 [TBL] [Abstract][Full Text] [Related]
4. Differing anti-proteinuric action of candesartan and losartan in chronic renal disease. Matsuda H; Hayashi K; Homma K; Yoshioka K; Kanda T; Takamatsu I; Tatematsu S; Wakino S; Saruta T Hypertens Res; 2003 Nov; 26(11):875-80. PubMed ID: 14714578 [TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin system in two genetically normotensive strains of Lyon rats. Lantelme P; Lo M; Sassard J Am J Hypertens; 2000 Mar; 13(3):283-9. PubMed ID: 10777033 [TBL] [Abstract][Full Text] [Related]
6. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin. Lebel M; Rodrigue ME; Agharazii M; Larivière R Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776 [TBL] [Abstract][Full Text] [Related]
7. Four-week inhibition of the renin-angiotensin system in spontaneously hypertensive rats results in persistently lower blood pressure with reduced kidney renin and changes in expression of relevant gene networks. Byars SG; Prestes PR; Suphapimol V; Takeuchi F; De Vries N; Maier MC; Melo M; Balding D; Samani N; Allen AM; Kato N; Wilkinson-Berka JL; Charchar F; Harrap SB Cardiovasc Res; 2024 May; 120(7):769-781. PubMed ID: 38501595 [TBL] [Abstract][Full Text] [Related]
8. Effects of dual blockade of the renin angiotensin system in hypertensive type 2 diabetic patients with nephropathy. Matos JP; de Lourdes Rodrigues M; Ismerim VL; Boasquevisque EM; Genelhu V; Francischetti EA Clin Nephrol; 2005 Sep; 64(3):180-9. PubMed ID: 16175942 [TBL] [Abstract][Full Text] [Related]
9. Renal and metabolic disorders depend on the renin-angiotensin system in Lyon hypertensive rats associated with diabetes. Emonnot L; Cohen R; Lo M Am J Hypertens; 2008 Jun; 21(6):657-62. PubMed ID: 18443571 [TBL] [Abstract][Full Text] [Related]
10. Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy. Kim HJ; Ryu JH; Han SW; Park IK; Paik SS; Park MH; Paik DJ; Chung HS; Kim SW; Lee JU Nephron Physiol; 2004; 97(4):p58-65. PubMed ID: 15331931 [TBL] [Abstract][Full Text] [Related]
11. Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin system. Sebeková K; Lill M; Boor P; Heidland A; Amann K Am J Nephrol; 2009; 29(3):164-70. PubMed ID: 18753741 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with Angiotensin-converting enzyme inhibitors. Seeman T; Pohl M; Misselwitz J; John U Kidney Blood Press Res; 2009; 32(6):440-4. PubMed ID: 20016211 [TBL] [Abstract][Full Text] [Related]
13. Cardioprotective action of perindopril versus candesartan in renovascular hypertensive rats. Nagai M; Horikoshi K; Izumi T; Seki S; Taniguchi M; Taniguchi I; Mochizuki S Cardiovasc Drugs Ther; 2004 Sep; 18(5):353-62. PubMed ID: 15717137 [TBL] [Abstract][Full Text] [Related]
14. Reduction in arterial stiffness with angiotensin II antagonism and converting enzyme inhibition. A comparative study among malay hypertensive subjects with a known genetic profile. Rehman A; Ismail SB; Naing L; Roshan TM; Rahman AR Am J Hypertens; 2007 Feb; 20(2):184-9. PubMed ID: 17261465 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of the Renin-Angiotensin System Post Myocardial Infarction Prevents Inflammation-Associated Acute Cardiac Rupture. Gao XM; Tsai A; Al-Sharea A; Su Y; Moore S; Han LP; Kiriazis H; Dart AM; Murphy AJ; Du XJ Cardiovasc Drugs Ther; 2017 Apr; 31(2):145-156. PubMed ID: 28204966 [TBL] [Abstract][Full Text] [Related]
16. Pivotal role of the renin-angiotensin system in Lyon hypertensive rats. Lantelme P; Lo M; Luttenauer L; Sassard J Am J Physiol; 1997 Nov; 273(5):R1793-9. PubMed ID: 9374825 [TBL] [Abstract][Full Text] [Related]
17. The preclinical basis of the therapeutic evaluation of losartan. Timmermans PB; Wong PC; Chiu AT; Smith RD J Hypertens Suppl; 1995 Jul; 13(1):S1-13. PubMed ID: 18800450 [TBL] [Abstract][Full Text] [Related]
18. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies. Luño J; Barrio V; Goicoechea MA; González C; de Vinuesa SG; Gómez F; Bernis C; Espinosa M; Ahijado F; Gómez J; Escalada P Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855 [TBL] [Abstract][Full Text] [Related]
19. Renoprotection persists after cessation of treatment with very low doses of perindopril in Lyon hypertensive rats. Egan EJ; Dijoud F; Gilibert S; Sassard J Acta Pharmacol Sin; 2008 Nov; 29(11):1296-300. PubMed ID: 18954523 [TBL] [Abstract][Full Text] [Related]
20. Long-term effect on blood pressure of early brief treatment by different antihypertensive agents: a study in the prague hypertensive rat. Heller J; Hellerová S Kidney Blood Press Res; 1998; 21(6):445-51. PubMed ID: 9933830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]